Huichan He

First Affiliated Hospital of Guangzhou Medical University — China

Medicine · Health Sciences

28h-index2.2kcitations108works3.72yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(20), RNA Research and Splicing(15), RNA modifications and cancer(14), MicroRNA in disease regulation(12), Circular RNAs in diseases(11)

Publications108 total

Fndc5 modification optimizes the therapeutic effect of rat MSCs on sepsis-induced ALI/ARDS via activating the PI3K/AKT signaling pathway
Stem Cell Research & Therapy·2026Open Access
Targeting FGFR1 enhances olaparib sensitivity via MAPK-mediated BRCA2 downregulation in mCRPC
Translational Andrology and Urology·2025Open Access
Omics integration identified CRIP2 as a key mediator of olaparib resistance in prostate cancer
Translational Andrology and Urology·2025Open Access
A Promising Prognostic Signature Consisting of Fatty Acid Metabolism Genes based on Machine Learning Predicts Biochemical Recurrence and Aids ARSI Therapy in Prostate Cancer
Journal of Cancer·2025Open Access
ACACA depletion activates the cPLA2–arachidonic acid–NF-κB axis to drive inflammatory reprogramming in androgen receptor-independent prostate cancer
Cell Communication and Signaling·2025· 1 citedOpen Access
Characterization of the Biochemical Recurrence Prediction Ability and Progression Correlation of Peroxiredoxins Family in Prostate Cancer Based on Integrating Single‐Cell <scp>RNA</scp> ‐Seq and Bulk <scp>RNA</scp> ‐Seq Cohorts
Cancer Medicine·2025· 1 citedOpen Access
Metformin inhibits the progression of castration-resistant prostate cancer by regulating PDE6D induced purine metabolic alternation and cGMP / PKG pathway activation
Cancer Letters·2025· 7 cited
Depletion of Acetyl‐CoA Carboxylase 1 Facilitates Epithelial‐Mesenchymal Transition in Prostate Cancer Cells by Activating the MAPK/ERK Pathway
MedComm·2025· 2 citedOpen Access
Development and validation of a kinase-related gene signature as a novel diagnostic and prognostic model for prostate cancer
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease·2025· 4 cited
Fluorescent Nanoparticles Achieve Efficient Photothermal Conversion and Enhanced Antitumor Efficacy Through Intermolecular Aggregation‐Caused Quenching
Aggregate·2024· 13 citedOpen Access
N1-methyladenosine RNA methylation patterns are associated with an increased risk to biochemical recurrence in prostate cancer and serve as a potential novel biomarker for patient stratification
International Immunopharmacology·2024· 4 cited
Evaluation of glucocorticoid-related genes reveals GPD1 as a therapeutic target and regulator of sphingosine 1-phosphate metabolism in CRPC
Cancer Letters·2024· 6 cited
Identifying CDCA3 as a pivotal biomarker for predicting outcomes and immunotherapy efficacy in pan-renal cell carcinoma
Translational Andrology and Urology·2024· 1 citedOpen Access
A Unique Approach: Biomimetic Graphdiyne-Based Nanoplatform to Treat Prostate Cancer by Combining Cuproptosis and Enhanced Chemodynamic Therapy
International Journal of Nanomedicine·2024· 12 citedOpen Access
Investigation of the correlation between platelet antibodies and peripheral blood cytopenia in patients with hepatocellular carcinoma
Scientific Reports·2024· 1 citedOpen Access
Machine learning–based integration develops a stress response stated T cell (Tstr)–related score for predicting outcomes in clear cell renal cell carcinoma
International Immunopharmacology·2024· 5 citedOpen Access
Correlation of PIK3R1 overexpression with CD73+ FOXP3+ regulatory T cell infiltration and its role in tumor progression and prognosis prediction in gastric cancer
Research Square (Research Square)·2024Open Access
ACOX2 Serves as a Favorable Indicator Related to Lipid Metabolism and Oxidative Stress for Biochemical Recurrence in Prostate Cancer
Journal of Cancer·2024· 9 citedOpen Access
Metformin escape in prostate cancer by activating the PTGR1 transcriptional program through a novel super-enhancer
Signal Transduction and Targeted Therapy·2023· 18 citedOpen Access
A reactive oxygen species–related signature to predict prognosis and aid immunotherapy in clear cell renal cell carcinoma
Frontiers in Oncology·2023· 4 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Weide Zhong(48), Zhaodong Han(34), Qi-Shan Dai(22), Yuxiang Liang(20), Funeng Jiang(20), Xue‐cheng Bi(14), Zhuoyuan Lin(13), Rujun Mo(11), Chao Cai(10), Xin Fu(10), Yangjia Zhuo(10), Yongkang Ye(10), Guohua Zeng(10), Yanqiong Zhang(9), Chin‐Lee Wu(9), Xiaohui Ling(8), Jianming Lü(8), Yuxiang Liang(8), Jianguo Zhu(8), Yingke Liang(7)